Mark McDade, CEO at PDL BIOPHARMA, INC. (PDLI), sold 9,000 shares at $20.49 ($186K) on 2007-01-11, disclosed to the SEC on 2007-01-16.
Scheduled sale ($186k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.49 | 1,500 | $31K | 16.5% |
| 2 | $20.55 | 1,500 | $31K | 16.5% |
| 3 | $20.73 | 1,500 | $31K | 16.7% |
| 4 | $20.82 | 1,500 | $31K | 16.8% |
| 5 | $20.83 | 1,500 | $31K | 16.8% |
| 6 | $20.85 | 1,500 |
| $31K |
| 16.8% |
| Total | $20.71 avg | 9,000 | $186K | 100% |
| Filing → |
| AIMT | BUY | 2015-08-11 | $267K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-07-17 | $9K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-05-08 | $9K | — | Filing → |